Radiotherapy for neovascular age-related macular degeneration

Cochrane Database of Systematic Reviews

Volumn 2020, Issue 8, 2020, Pages

  Evans, Jennifer R ^a   Igwe, Chinedu ^b   Jackson, Timothy L ^c   Chong, Victor ^d  

^a LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^b EPSOM AND ST HELIER UNIVERSITY HOSPITALS NHS TRUST   (United Kingdom)

^c KING'S COLLEGE LONDON   (United Kingdom)

^d OXFORD EYE HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

VASCULOTROPIN ANTIBODY; VASCULOTROPIN A;

BEST CORRECTED VISUAL ACUITY; BLOOD VESSEL; BRACHYTHERAPY; CATARACT; CONTRAST SENSITIVITY; EXTERNAL BEAM RADIOTHERAPY; HUMAN; META ANALYSIS; MULTICENTER STUDY (TOPIC); PRIORITY JOURNAL; QUALITY OF LIFE; RADIATION DOSE; RANDOMIZED CONTROLLED TRIAL (TOPIC); RETINOPATHY; REVIEW; STEREOTACTIC TREATMENT; SUBRETINAL NEOVASCULARIZATION; SYSTEMATIC REVIEW; TEAR OSMOLARITY; WET MACULAR DEGENERATION; ADVERSE EVENT; COMPLICATION; EYE; MACULAR DEGENERATION; MULTIMODALITY CANCER THERAPY; PROCEDURES; RADIATION INJURY; RADIATION RESPONSE; RADIOTHERAPY DOSAGE; STATISTICAL BIAS; VISUAL ACUITY;

BIAS; BRACHYTHERAPY; COMBINED MODALITY THERAPY; EYE; HUMANS; MACULAR DEGENERATION; RADIATION INJURIES; RADIOTHERAPY; RADIOTHERAPY DOSAGE; RANDOMIZED CONTROLLED TRIALS AS TOPIC; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VISUAL ACUITY;

EID: 85089923780     PISSN: None     EISSN: 1469493X     Source Type: Journal    
DOI: 10.1002/14651858.CD004004.pub4     Document Type: Review

References (74)

1. Treatment of Age-related Macular Degeneration with Low-dose Radiation Therapy Study Group. The results of randomized controlled trial of low-dose radiation for wet-type age-related macular degeneration on a 1-year term basis. Nippon Ganka Gakkai Zasshi 2003;107(6):326-30. x-wiley/crsRef/2765659
2. Marcus DM, Peskin E, Maguire M, Weissgold D, Alexander J, Fine S, et al The AMDRT Research Group. The age-related macular degeneration radiotherapy trials (AMDRT): one year results from a pilot study. American Journal of Ophthalmology 2004;138(5):818-28. x-wiley/crsRef/2765661
3. Anders N, Stahl H, Dorn A, Walkow T, Hosten N, Wust P, et al. Radiotherapy of exudative senile macular degeneration. A prospective controlled study [Strahlentherapie der exsudativen altersabhangigen Makuladegeneration. Eine prospektive kontrollierte Studie]. Ophthalmologe 1998;95(11):760-4. x-wiley/crsRef/2765663
4. Bergink GJ, Hoyng CB, Van der Maazen RW, Vingerling JR, van Daal WA, Deutman AF. A randomised controlled trial of efficacy of radiation therapy in the control of subfoveal neovascularisation in age-related macular degeneration: radiation verses observation. Graefe's Archive for Clinical and Experimental Ophthalmology 1998;236(5):321-5. x-wiley/crsRef/2765665
5. Hoyng CB, Tromp AI, Meulendijks CFM, Leys A, van der Maazen RWM, Deutman AF, et al. Side effects after radiotherapy of age-related macular degeneration with the Nijmegen technique. Graefe's Archive for Clinical and Experimental Ophthalmology 2002;240(5):337-41. x-wiley/crsRef/2765666
6. Dugel PU, Bebchuk JD, Nau J, Reichel E, Singer M, Barak A, et al. Epimacular brachytherapy for neovascular age-related macular degeneration: a randomized, controlled trial (CABERNET). Ophthalmology 2013;120(2):317-27. x-wiley/crsRef/2765668
7. Jackson TL, Dugel PU, Bebchuk JD, Smith KR, Petrarca R, Slakter JS, et al. Epimacular brachytherapy for neovascular age-related macular degeneration (CABERNET): Fluorescein angiography and optical coherence tomography. Ophthalmology 2013;120(2):1597-603. x-wiley/crsRef/2765669
8. Char DH, Irvine AI, Posner MD, Quivey J, Phillips TL, Kroll S. Randomised trial of radiation for age-related macular degeneration. American Journal of Ophthalmology 1999;127(5):574-8. x-wiley/crsRef/2765671
9. Ciulla TA, Danis RP, Klein SB, Malinovsky VE, Soni PS, Pratt LM, et al. Proton therapy for exudative age-related macular degeneration: a randomized, sham-controlled clinical trial. American Journal of Ophthalmology 2002;134(6):905-6. x-wiley/crsRef/2765673
10. Eter N, Schuller H, Spitznas M. Radiotherapy for age-related macular degeneration: is there a benefit for classic CNV? International Ophthalmology 2002;24(1):13-9. x-wiley/crsRef/2765675
11. Freiberg FJ, Michels S, Muldrew A, Slakter J, O'Shaughnessy D, Czeszynski A et al. Microvascular abnormalities secondary to radiation therapy in neovascular age-related macular degeneration: findings from the INTREPID clinical trial. British Journal of Ophthalmology 2019;103(4):459-74. x-wiley/crsRef/14237248
12. Jackson TL, Chakravarthy U, Kaiser PK, Slakter JS, Jan E, Bandello F, et al. Stereotactic radiotherapy for neovascular age-related macular degeneration: 52-week safety and efficacy results of the INTREPID study. Ophthalmology 2013;120(9):1893-900. x-wiley/crsRef/2765677
13. Jackson TL, Chakravarthy U, Slakter JS, Muldrew A, Shusterman EM, O'Shaughnessy D, et al. Stereotactic radiotherapy for neovascular age-related macular degeneration: year 2 results of the INTREPID study. Ophthalmology 2015;122(1):138-45. x-wiley/crsRef/14237249
14. Jackson TL, Dugel PU, Bebchuk JD, Smith KR, Petrarca R, Slakter JS, et al The CABERNET Study Group. Epimacular brachytherapy for neovascular age-related macular degeneration (CABERNET) fluorescein angiography and optical coherence tomography. Ophthalmology 2013;120(9):1597-1603. x-wiley/crsRef/14237250
15. Jackson TL, Shusterman EM, Arnoldussen M, Chell E, Wang K, Moshfeghi DM, et al. Stereotactic radiotherapy for wet age-related macular degeneration (INTREPID): influence of baseline characteristics on clinical response. Retina 2015;35(2):194-204. x-wiley/crsRef/2765679
16. Jaakkola A, Heikkonen J, Tommila P, Laatikainen L, Immonen I. Strontium plaque brachytherapy for exudative age-related macular degeneration: three-year results of a randomized study. Ophthalmology 2005;112(4):567-73. x-wiley/crsRef/2765681
17. Kacperek A, Briggs M, Sheen M, Damato BE, Errington RD, Harding S. Macular degeneration treatment at Clatterbridge Centre for oncology: treatment and preliminary results. Physica Medica 2001;17(Suppl 3):7-9. x-wiley/crsRef/2765683
18. Kobayashi H, Kobayashi K. Age-related macular degeneration: long-term results of radiotherapy for subfoveal neovascular membranes. American Journal of Ophthalmology 2000;130(5):617-35. x-wiley/crsRef/2765685
19. Marcus DM, Camp MW, Sheils WC, McIntosh SB, Leibach DB, Johnson MH, et al. Sham radiation in clinical trials assessing radiotherapy for exudative age-related macular degeneration. Retina 1999;19(6):525-30. x-wiley/crsRef/2765687
20. Marcus DM, Sheils C, Johnson MH, McIntosh SB, Leibach DB, Maguire A, et al. External beam irradiation of subfoveal choroidal neovascularisation complicating age-related macular degeneration. Archives of Ophthalmology 2001;1(19):171-80. x-wiley/crsRef/2765688
21. Jackson TL, Desai R, Simpson A, Neffendorf JE, Petrarca R, Smith K, et al The Macular Epiretinal Brachytherapy versus Ranibizumab (Lucentis) Only Treatment (MERLOT) Study Group. Epimacular brachytherapy for previously treated neovascular age-related macular degeneration (MERLOT): a phase 3 randomized controlled trial. Ophthalmology 2016;123(6):1287-96. x-wiley/crsRef/14237252
22. Jackson TL, Soare C, Petrarca C, Simpson A, Neffendorf JE, Petrarca R, et al. Evaluation of month-24 efficacy and safety of epimacular brachytherapy for previously treated neovascular age-related macular degeneration: the MERLOT randomized clinical trial. JAMA Ophthalmology 2020;138(8):1-8. x-wiley/crsRef/14309552
23. Lu J, Daftari I, Mishra K, Moshiri A, Park SS. Changes in subretinal hyperreflective material in phase I/II study of proton beam irradiation combined with anti-VEGF therapy for exudative age-related macular degeneration. Investigative Ophthalmology and Visual Science 2017;58(8):ARVO E-abstract 4831. x-wiley/crsRef/14237254
24. NCT01213082. Prospective trial of proton beam combined with anti-VEGF therapy for exudative age-related macular degeneration (AMD) (PBAMD2). clinicaltrials.gov/ct2/show/NCT01213082 (first received 1 October 2010). x-wiley/crsRef/14237255
25. Osmanovic S, Moisseiev E, Mishra KK, Daftari I, Moshiri A, Morse L, et al. Phase I/II randomized study of proton beam with anti-vascular endothelial growth factor for exudative age-related macular degeneration: one-year results. Ophthalmology Retina 2017;1(3):217-26. x-wiley/crsRef/14237256
26. Wong S, Daftari I, Mishra K, Migacz J V, Gorczynska I, Moshiri A et al. Fluorescein and OCT angiographic evaluation of choroidal neovascular membrane following proton beam and intravitreal anti-VEGF therapy for exudative AMD: 2-year follow up. Investigative Ophthalmology and Visual Science 2017;58(8):ARVO E-abstract 370. x-wiley/crsRef/14237257
27. Bellmann C, Unnebrink K, Rubin GS, Miller D, Holz FG. Visual acuity and contrast sensitivity in patients with neovascular age-related macular degeneration. Results from the Radiation Therapy for Age-Related Macular Degeneration (RAD-) Study. Graefe's Archive for Clinical and Experimental Ophthalmology 2003;241(12):968-74. x-wiley/crsRef/2765690
28. Holz FG, Unnebrink K, Staudt S, Voelcker HE, Wannenmacher M, Bellmann C, et al. Two-years results of a prospective, randomized, double-blind multicenter trial on radiation therapy for neovascular ARMD. American Academy of Ophthalmology 2000:115. x-wiley/crsRef/2765691
29. Holz FG, Voelcker HE, Engenhart-Cabillic R, Bellmann C, Unnebrink K, Debus J, et al. A prospective randomized, controlled, double-blind multicenter trial on radiation therapy for subfoveal CNV secondary to ARMD. American Academy of Ophthalmology 1999:247-8. x-wiley/crsRef/2765692
30. The Radiation Therapy for Age-Related Macular Degeneration (RAD) Group. A prospective, randomised, double-masked trial on radiation therapy for neovascular age-related macular degeneration. Ophthalmology 1999;106(12):2239-47. x-wiley/crsRef/2765693
31. Vacha P, Debus J, Wiegel T, Schuchardt U, Schaefer U, Engenhart-Cabillic R. A prospective randomized, double-blind multicenter-trial on radiation therapy for neovascular age-related macular degeneration. European Journal of Cancer 2001;37:275 (A1015). x-wiley/crsRef/2765694
32. Hart PM, Chakravarthy U, Mackenzie G, Chisholm IH, Bird AC, Stevenson MR, et al. Visual outcomes in the subfoveal radiotherapy study: a randomized controlled trial of teletherapy for age-related macular degeneration. Archives of Ophthalmology 2002;120(8):1029-38. x-wiley/crsRef/2765696
33. Stevenson MR, Hart PM, Chakravarthy U, MacKenzie G, Bird AC, Owens SL, et al. Visual functioning and quality of life in the SubFoveal Radiotherapy Study (SFRADS): SFRADS report 2. British Journal of Ophthalmology 2005;89(8):1045-51. x-wiley/crsRef/2765697
34. Valmaggia C, Ries G, Ballinari P. A 5-year follow-up study for distance visual acuity after low dose radiation on subfoveal choroidal neovascularization in age-related macular degeneration. Documenta Ophthalmologica 2001;103(3):201-9. x-wiley/crsRef/2765699
35. Valmaggia C, Ries G, Ballinari P. Radiotherapy for subfoveal choroidal neovascularization in age-related macular degeneration: a randomized clinical trial. American Journal of Ophthalmology 2002;133(4):521-9. x-wiley/crsRef/2765700
36. Avila MP, Farah ME, Santos A, Duprat JP, Woodward BW, Nau J. Twelve-month short-term safety and visual-acuity results from a multicentre prospective study of epiretinal strontium-90 brachytherapy with bevacizumab for the treatment of subfoveal choroidal neovascularisation secondary to age-related macular degeneration. British Journal of Ophthalmology 2009;93(3):305-9. x-wiley/crsRef/2765702
37. Barak A, Hauser D, Yipp P, Morse L, Leigh B, Kubo D, et al. A phase I trial of stereotactic external beam radiation for subfoveal choroidal neovascular membranes in age-related macular degeneration. British Journal of Radiology 2005;78(933):827-31. x-wiley/crsRef/2765704
38. Bergink GJ, Deutman AF, Van Den Broek JECM, Van Daal WAJ, Van Der Maazen RMW. Radiation therapy for age-related subfoveal choroidal neovascular membranes. Documenta Ophthalmologica 1995;90(1):67-74. x-wiley/crsRef/2765706
39. Brown GC, Freire JE, Vander J, Brady LW, Shields CL, Shields JA, et al. Strontium-90 brachytherapy for exudative, age related macular degeneration: a pilot study. International Journal of Radiation Oncology, Biology, Physics 1997;39(2, Suppl 1):332 (A2184). x-wiley/crsRef/2765708
40. Churei H, Ohkubo K, Nakajo M, Hokotate H, Baba Y, Ideue J, et al. External-beam radiation therapy for age-related macular degeneration: Two years' follow-up results at a total dose of 20 Gy in 10 fractions. Radiation Medicine 2004;22(6):398-404. x-wiley/crsRef/2765710
41. Eter N, Schuller H. External beam radiotherapy for age-related macular degeneration causes transient objective changes in tear-film function. Graefe's Archive for Clinical and Experimental Ophthalmology 2001;239(12):923-6. x-wiley/crsRef/2765712
42. Friedrichsen EJ, Slater JD, Hagele JE, Chan CK, Yonemoto LT, Garcia C A, et al. Proton beam irradiation of subfoveal choroidal neovascularization: a pilot study of single-dose 800 cGy and 1400 cGy. American Academy of Ophthalmology 1996:135. x-wiley/crsRef/2765714
43. Heier JS, Farah M, Duprat JP, Avila M, Fujii GY, Rossi J, et al. A study to evaluate the safety and feasibility of radiotherapy and bevacizumab (Avastin) for the treatment of subfoveal choroidal neovascularization (CNV) secondary to age-related macular degeneration (AMD). The Macular Society 2008:186. x-wiley/crsRef/2765716
44. Honjo M, Mandai M, Hiroshiba N, Miyamoto H, Takahashi M, Ogura Y, et al. Evaluation of the early-phase response of neovascular membrane in age-related macular degeneration to low-dose radiation. Japanese Journal of Clinical Ophthalmology 1997;51(9):1563-9. x-wiley/crsRef/2765718
45. Jackson TL, Kirkpatrick L, Tang G, Prasad S. Cost analysis comparing adjuvant epimacular brachytherapy with anti-VEGF monotherapy for the management of neovascular age-related macular degeneration. Eye 2012;26(4):557-63. x-wiley/crsRef/2765720
46. Mandai M, Takahashi M, Miyamoto H, Hiroshiba N, Kimura H, Ogura Y, et al. Long term effects of radiation treatment for age-related macular degeneration. Japanese Journal of Clinical Ophthalmology 1998;52:567-71. x-wiley/crsRef/2765722
47. Mandai M, Takahashi M, Miyamoto H, Hiroshiba N, Kimura H, Ogura Y, et al. Long-term outcome after radiation therapy for subfoveal choroidal neovascularization associated with age-related macular degeneration. Japanese Journal of Ophthalmology 2000;44(5):530-7. x-wiley/crsRef/2765724
48. Marcus DM, Sheils WC, Young JO, McIntosh SB, Johnson MH, Alexander J, et al. Radiotherapy for recurrent choroidal neovascularisation complicating age related macular degeneration. British Journal of Ophthalmology 2004;88(1):114-9. x-wiley/crsRef/2765726
49. Matsuhashi H, Takahashi D, Noda Y, Mariya Y, Tarusawa N, Yoshimoto H, et al. Low-dose radiation, therapy for choroidal neovascularization in age-related macular degeneration. Nippon Ganka Gakkai Zasshi 1996;100(10):803-9. x-wiley/crsRef/2765728
50. Matsuhashi H, Noda Y, Takahashi D, Mariya Y. Radiation therapy for small choroidal neovascularization in age-related macular degeneration. Japanese Journal of Ophthalmology 2000;44(6):653-60. x-wiley/crsRef/2765730
51. NCT01833325. Proton radiation therapy for macular degeneration. clinicaltrials.gov/ct2/show/NCT01833325 (first received 16 April 2013). x-wiley/crsRef/14237258
52. Postgens H, Bodanowitz S, Kroll P. Low-dose radiation therapy for age-related macular degeneration. Graefe's Archive for Clinical and Experimental Ophthalmology 1997;235(10):656-61. x-wiley/crsRef/2765734
53. Reichel E, Farah M, Duprat JP, Avila M, Fujii GY, Rossi, et al. A study to evaluate the safety and feasibility of radiotherapy and bevacizumab (Avastin) for the treatment of subfoveal choroidal neovascularization (CNV) secondary to age-related macular degeneration. Investigative Ophthalmology and Visual Science 2007;48(13):ARVO E-Abstract 3657. x-wiley/crsRef/14237259
54. Saric B, Sikic J, Katusic D, Vukojevic N. Brachytherapy - optional treatment for choroidal neovascularization secondary to age-related macular degeneration. Collegium Antropologicum 2001;25 Suppl:89-96. x-wiley/crsRef/2765738
55. Taniguchi T, Mandai M, Honjo M, Matsuda N, Miyamoto H, Takahashi M, et al. Radiation treatment for age-related macular degeneration. Japanese Journal of Clinical Ophthalmology 1996;50:1821-6. x-wiley/crsRef/2765740
56. Tholen AM, Meister A, Bernasconi PP, Messmer EP. Radiotherapy for choroidal neovascularization (CNV) in age-related macular degeneration (AMD) [Radiotherapie von choroidalen Neovaskularisationen (CNV) bei altersabhangiger Makuladegeneration (AMD)]. Klinische Monatsblatter fur Augenheilkunde 2000;216(2):112-5. x-wiley/crsRef/2765742
57. Tholen AM, Meister A, Bernasconi PP, Messmer EP. Radiotherapy for choroidal neovascularization in age-related macular degeneration. A pilot study using low- versus high-dose photon beam radiation [Radiotherapie von subretinalen Neovaskularisationsmembranen bei altersabhangiger Makuladegeneration (AMD). Niedrig- versus hochdosierte Photonenbestrahlung]. Ophthalmologe 1998;95(10):691-8. x-wiley/crsRef/2765743
58. Zambarakji HJ, Lane AM, Ezra E, Gauthier D, Goitein M, Adams JA, et al. Proton beam irradiation for neovascular age-related macular degeneration. Ophthalmology 2006;113(11):2012-9. x-wiley/crsRef/2765745
59. NCT02243878. Stereotactic radiotherapy for wet AMD (STAR). clinicaltrials.gov/ct2/show/NCT02243878 (first received 18 September 2014). x-wiley/crsRef/14237261
60. Englander M, Kaiser PK. Combination therapy for the treatment of neovascular age-related macular degeneration. Current Opinion in Ophthalmology 2013;24(3):233-8.
61. Evans JR, Wong TY. Age-related macular degeneration. In: Johnson GJ, Minassian DC, Weale RA, West SK, Gower EW, Kuper H, Lindfield R, editors(s). The Epidemiology of Eye Disease. 3rd edition. London: Imperial College Press, 2012.
62. Flaxman SR, Bourne RR, Resnikoff S, Ackland P, Braithwaite T, Cicinelli MV, et al. Global causes of blindness and distance vision impairment 1990-2020: a systematic review and meta-analysis. Lancet Global Health 2017;5(12):e1221-34.
63. Glanville JM, Lefebvre C, Miles JN, Camosso-Stefinovic J. How to identify randomized controlled trials in MEDLINE: ten years on. Journal of the Medical Library Association 2006;94(2):130-6.
64. GRADE Working Group, McMaster University GRADEpro GDT. Version accessed prior to 7 May 2020. Hamilton (ON): GRADE Working Group, McMaster University. Available at gradepro.org.
65. Hart PM, Chakravarthy U, Stevenson MR, Jamison JQ. A vision specific functional index for use in patients with age related macular degeneration. British Journal of Ophthalmology 1999;83(10):1115-20.
66. Kim LN, Mehta H, Barthelmes D, Nguyen V, Gillies MC. Meta-analysis of real-world outcomes of intravitreal ranibizumab for the treatment of neovascular age-related macular degeneration. Retina 2016;36(8):1418-31.
67. Kirkham JJ, Dwan KM, Altman DG, Gamble C, Dodd S, Smyth R, et al. The impact of outcome reporting bias in randomised controlled trials on a cohort of systematic reviews. BMJ 2010;340:c365.
68. Kishan AU, Modjtahedi BS, Morse LS, Lee P. Radiation therapy for neovascular age-related macular degeneration. International Journal of Radiation Oncology, Biology, Physics 2013;85(3):583-97.
69. Li E, Donati S, Lindsley KB, Krzustolik MG, Virgili G. Treatment regimens for administration of anti-vascular endothelial growth factor agents for neovascular age-related macular degeneration. Cochrane Database of Systematic Reviews 2020, Issue 5. Art. No: CD012208. [DOI: 10.1002/14651858.CD012208.pub2]
70. Mendez CA, Ehlers JP. Radiation therapy: age-related macular degeneration. Developments in Ophthalmology 2013;52:75-84.
71. Nordic Cochrane Centre, The Cochrane Collaboration Review Manager 5 (RevMan 5). Version 5.3. Copenhagen: Nordic Cochrane Centre, The Cochrane Collaboration, 2014.
72. Silva RA, Moshfeghi AA, Kaiser PK, Singh RP, Moshfeghi DM. Radiation treatment for age-related macular degeneration. Seminars in Ophthalmology 2011;26(3):121-30.
73. Evans J R, Sivagnanavel V, Chong V. Radiotherapy for neovascular age-related macular degeneration. Cochrane Database of Systematic Reviews 2010, Issue 5. Art. No: CD004004. [DOI: 10.1002/14651858.CD004004.pub3]
74. Sivagnanavel V, Evans JR, Ockrim Z, Chong V. Radiotherapy for neovascular age-related macular degeneration. Cochrane Database of Systematic Reviews 2004, Issue 4. Art. No: CD004004. [DOI: 10.1002/14651858.CD004004.pub2]